Herpes Simplex Virus (HSV) Suppression with Valacyclovir Reduces Rectal and Blood Plasma HIV‐1 Levels in HIV‐1/HSV‐2–Seropositive Men: A Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial - Concepedia

Concepedia

Publication | Open Access

Herpes Simplex Virus (HSV) Suppression with Valacyclovir Reduces Rectal and Blood Plasma HIV‐1 Levels in HIV‐1/HSV‐2–Seropositive Men: A Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial

DOI Full Paper Access

185

Citations

37

References

2007

Year

Richard A. Zuckerman, Aldo Lucchetti, William L. H. Whittington, Jorge L. Sánchez, Robert W. Coombs, Rosario Zuñiga, Amalia Magaret, Anna Wald, Lawrence Corey, Connie Celum

The Journal of Infectious Diseases

Abstract

Valacyclovir significantly reduces rectal and plasma HIV-1 levels in HIV-1/HSV-2-coinfected men. HSV suppression may provide clinical benefits to persons not receiving highly active ART as well as public health benefits.

References

	Year	Citations

Page 1